Literature DB >> 15750268

A trial to assess the amount of insulin antibodies in diabetic patients by surface plasmon resonance.

Masahiko Kure1, Yoshiya Katsura, Hiroshi Kosano, Masayuki Noritake, Toshiya Watanabe, Yoshiki Iwaki, Hideo Nishigori, Takeshi Matsuoka.   

Abstract

OBJECTIVE: To measure the amount and affinity of insulin antibodies, we performed a trial to establish a new method for quantitative and qualitative analysis of these antibodies by using surface plasmon resonance (BIAcore system).
METHODS: Real-time detection of insulin antibody interaction and kinetic analysis were performed using the BIAcore system. PATIENTS OR MATERIALS: Eight diabetic patients with insulin antibodies and whose fasting total immunoreactive insulin levels were more than 100 microU/ml were selected. The patients with and without recurrent hypoglycemia were classified into hypoglycemic episode-positive or hypoglycemic episode-negative groups, respectively. Seven diabetic patients without insulin antibodies were selected as controls.
RESULTS: In the 8 patients, the concentration of insulin antibodies ranged from 2.91 to 16.3 microg/ml and insulin antibodies were not detected in the control group. The apparent KD (dissociation constant) and kd (the dissociation rate constant) values of the patients were much larger than those seen for the anti-human insulin monoclonal antibody. The KD values were significantly higher in the hypoglycemic episode-positive group than in the hypoglycemic episode-negative group (p<0.05). No significant differences in the concentration, the ka (the association rate constant) and the kd values were noted between the groups.
CONCLUSION: The data suggests that insulin antibodies of the patients have an apparently lower affinity status in sera as compared with that for the anti-human insulin monoclonal antibody, and dissociate easily from the immune-complex in the sera, especially in cases where there is recurrent hypoglycemia in the patients. Therefore insulin antibody characteristics are one of the causative factors in hypoglycemic episodes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750268     DOI: 10.2169/internalmedicine.44.100

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Analytical and clinical challenges in a patient with concurrent type 1 diabetes, subcutaneous insulin resistance and insulin autoimmune syndrome.

Authors:  N Jassam; N Amin; P Holland; R K Semple; D J Halsall; G Wark; J H Barth
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2014-04-01

2.  NGF and proNGF Reciprocal Interference in Immunoassays: Open Questions, Criticalities, and Ways Forward.

Authors:  Francesca Malerba; Francesca Paoletti; Antonino Cattaneo
Journal:  Front Mol Neurosci       Date:  2016-08-03       Impact factor: 5.639

3.  Ligand-binding characteristics of feline insulin-binding immunoglobulin G.

Authors:  Takafumi Suzuki; Naohito Nishii; Satoshi Takashima; Tatsuya Matsubara; Atsushi Iwasawa; Hirofumi Takeuchi; Kohei Tahara; Tatsuyuki Hachisu; Hitoshi Kitagawa
Journal:  J Vet Med Sci       Date:  2015-06-09       Impact factor: 1.267

Review 4.  Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients.

Authors:  Xiaolei Hu; Fengling Chen
Journal:  Endocr Connect       Date:  2017-12-12       Impact factor: 3.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.